Net Cash Provided by (Used in) Operating Activities in USD of Vor Biopharma Inc. from Q1 2020 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Vor Biopharma Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q1 2020 to Q1 2025.
- Vor Biopharma Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$31.1M, a 1.97% decline year-over-year.
- Vor Biopharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$99.7M, a 0.63% increase from 2023.
- Vor Biopharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$100M, a 17.8% decline from 2022.
- Vor Biopharma Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$85.1M, a 23.1% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)